Virax Biolabs Group Limited (VRAX)

Virax Biolabs Group Revenue

In the fiscal year ending March 31, 2026, Virax Biolabs Group had annual revenue of $12.42K with 96.22% growth. Virax Biolabs Group had revenue of $10.82K in the half year ending March 31, 2026, a decrease of -86.47%. That makes Virax Biolabs Group the 47,229th largest company in the world by revenue and 7,158th in the United States.

• Revenue (ttm): $12.42K
• Revenue Growth: +96.22%
• P/S Ratio: 41.32
• Revenue / Employee: $478
• Employees: 26
• Market Cap: 485.76K

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	12.42K	6.09K	96.22%
Mar 31, 2025	6.33K	-150.09K	-95.95%
Mar 31, 2024	156.42K	147.86K	1,727.11%
Mar 31, 2023	8.56K	-	-
Mar 31, 2022	-	-	-
Mar 31, 2021	123.82K	23.94K	23.97%
Mar 31, 2020	99.88K	-	-

Data Source: Fiscal.ai Last updated: May 15, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Nov 7, 2026

Data Sources Report a data error